A61L 2300/802
Additives, excipients
Official title: Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants
A61L2300/802 (Additives, excipients) appears on 496 US grants and 715 published applications in this corpus.
Search patents in A61L- Granted patents
- 496
- Published applications
- 715
- Assignees
- 380
- Inventors
- 1,368
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 3 | 0 |
| 1989 | 2 | 0 |
| 1990 | 3 | 0 |
| 1991 | 4 | 0 |
| 1992 | 4 | 0 |
| 1993 | 4 | 0 |
| 1994 | 5 | 0 |
| 1995 | 11 | 0 |
| 1996 | 7 | 0 |
| 1997 | 7 | 0 |
| 1998 | 10 | 0 |
| 1999 | 9 | 0 |
| 2000 | 8 | 0 |
| 2001 | 3 | 2 |
| 2002 | 5 | 11 |
| 2003 | 9 | 27 |
| 2004 | 5 | 27 |
| 2005 | 11 | 23 |
| 2006 | 6 | 23 |
| 2007 | 11 | 25 |
| 2008 | 5 | 25 |
| 2009 | 4 | 19 |
| 2010 | 7 | 29 |
| 2011 | 16 | 24 |
| 2012 | 17 | 27 |
| 2013 | 24 | 25 |
| 2014 | 26 | 26 |
| 2015 | 29 | 49 |
| 2016 | 18 | 24 |
| 2017 | 25 | 26 |
| 2018 | 24 | 32 |
| 2019 | 22 | 37 |
| 2020 | 31 | 36 |
| 2021 | 15 | 46 |
| 2022 | 16 | 44 |
| 2023 | 26 | 34 |
| 2024 | 17 | 43 |
| 2025 | 27 | 23 |
| 2026 | 16 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Photocurable hemostatic composition29 Sep 2026US 12,746,305 B2Snvia Co., Ltd.
- Polysaccharide-based hydrogel scaffolds for wound care22 Sep 2026US 12,741,055 B2National University of Singapore
- Ecobiological treatment of side effects of radiotherapy15 Sep 2026US 12,734,272 B2Bionuclei
- Drug coated balloon1 Sep 2026US 12,721,977 B2Medtronic Vascular, Inc.
- Method for coating implant using heat4 Aug 2026US 12,697,413 B2Bs Research Co. Ltd.
- 3d printing composition for biomaterials8 Oct 2026US 2026/0308309 A1Tissium
- Injectable homogeneous gels comprising multiple forms of hyaluronic acid and methods for manufacturing thereof6 Aug 2026US 2026/0224777 A1Allergan Pharmaceuticals International Limited
- Biologic Composition And Method Of Use21 May 2026US 2026/0137833 A1Vivex Biologics Group, Inc.
- Hydrophilic medical products and hydration mediums for hydrating the same21 May 2026US 2026/0137841 A1Hollister Incorporated
- Drug coated devices and methods for the treatment of eye disease21 May 2026US 2026/0137842 A1J.D. Franco & Co., LLC
Most cited
By later US patents
- Collagen-polymer conjugates778US 5,162,430 ACollagen Corporation · 1992
- Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor615US 5,328,470 AThe Regents of the University of Michigan · 1994
- Biologically inert, biocompatible-polymer conjugates521US 5,324,775 ACollagen Corporation · 1994
- Collagen-polymer conjugates471US 5,328,955 ACollagen Corporation · 1994
- Drug-releasing coatings for medical devices464US 6,042,875 ASchneider (USA) Inc. · 2000